Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Operating Leases (2019 - 2021)

Cogent Biosciences (COGT) has 3 years of Operating Leases data on record, last reported at $1.4 million in Q3 2021.

  • For Q3 2021, Operating Leases fell 61.04% year-over-year to $1.4 million; the TTM value through Sep 2021 reached $1.4 million, down 61.04%, while the annual FY2020 figure was $3.2 million, 28.51% down from the prior year.
  • Operating Leases reached $1.4 million in Q3 2021 per COGT's latest filing, down from $2.0 million in the prior quarter.
  • Across five years, Operating Leases topped out at $5.6 million in Q1 2019 and bottomed at $1.4 million in Q3 2021.
  • Average Operating Leases over 3 years is $3.7 million, with a median of $3.7 million recorded in 2020.
  • Peak YoY movement for Operating Leases: decreased 23.6% in 2020, then tumbled 61.04% in 2021.
  • A 3-year view of Operating Leases shows it stood at $4.4 million in 2019, then decreased by 28.51% to $3.2 million in 2020, then tumbled by 54.42% to $1.4 million in 2021.
  • Per Business Quant database, its latest 3 readings for Operating Leases were $1.4 million in Q3 2021, $2.0 million in Q2 2021, and $2.6 million in Q1 2021.